BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15650051)

  • 1. Directing oncogenic fusion genes into stem cells via an SCL enhancer.
    Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1133-8. PubMed ID: 15650051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental impact of leukemic fusion genes on stem cell fate.
    Enver T; Tsuzuki S; Brown J; Hong D; Gupta R; Ford T; Egucchi MI; Egucchi M; Greaves M
    Ann N Y Acad Sci; 2005 Jun; 1044():16-23. PubMed ID: 15958693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
    Tsuzuki S; Seto M; Greaves M; Enver T
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesodermal patterning activity of SCL.
    Ismailoglu I; Yeamans G; Daley GQ; Perlingeiro RC; Kyba M
    Exp Hematol; 2008 Dec; 36(12):1593-603. PubMed ID: 18809240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
    Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
    Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
    Carella C; Bonten J; Rehg J; Grosveld GC
    Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells.
    Silberstein L; Sánchez MJ; Socolovsky M; Liu Y; Hoffman G; Kinston S; Piltz S; Bowen M; Gambardella L; Green AR; Göttgens B
    Stem Cells; 2005 Oct; 23(9):1378-88. PubMed ID: 16051983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
    Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
    Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-injury-induced reactivation of hemangioblastic precursor cells.
    Dekel B; Metsuyanim S; Garcia AM; Quintero C; Sanchez MJ; Izraeli S
    Leukemia; 2008 Jan; 22(1):103-13. PubMed ID: 17898790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
    Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
    Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity.
    Morrow M; Horton S; Kioussis D; Brady HJ; Williams O
    Blood; 2004 May; 103(10):3890-6. PubMed ID: 14726384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells.
    Dobbin E; Corrigan PM; Walsh CP; Welham MJ; Freeburn RW; Wheadon H
    Leuk Res; 2008 Oct; 32(10):1554-64. PubMed ID: 18355917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ; Wu K; Morrone G; Moore MA
    Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformation.
    Lyons R; Williams O; Morrow M; Sebire N; Hubank M; Anderson J
    Leuk Res; 2010 Jan; 34(1):109-15. PubMed ID: 19628279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of Tel-TrkC chimeric transcripts is more specific than TrkC immunoreactivity for the diagnosis of congenital fibrosarcoma.
    Dubus P; Coindre JM; Groppi A; Jouan H; Ferrer J; Cohen C; Rivel J; Copin MC; Leroy JP; de Muret A; Merlio JP
    J Pathol; 2001 Jan; 193(1):88-94. PubMed ID: 11169520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish scl functions independently in hematopoietic and endothelial development.
    Dooley KA; Davidson AJ; Zon LI
    Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEL-JAK2 transgenic mice develop T-cell leukemia.
    Carron C; Cormier F; Janin A; Lacronique V; Giovannini M; Daniel MT; Bernard O; Ghysdael J
    Blood; 2000 Jun; 95(12):3891-9. PubMed ID: 10845925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
    Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
    Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.